Form 4 for STE Steris
Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-02 · accession 0001209191-23-034762 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-06 | 2023-06-02 | STE | Madsen Julia | Senior VP, Life Sciences | F - Tax | $205.47 | -247 | 8,722 | -3% | -$50.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-06-02 | F | D | 247 | $205.47 | 8,722 | D | — | — | (F1) 247 shares were withheld from the 712 restricted shares that vested on June 2, 2023. These 247 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 712 ordinary shares were awarded to Ms. Madsen on June 2, 2021 and June 2, 2022. These vested shares were valued at the NYSE closing market price on June 2, 2023. (F2) As of June 2, 2023, 4,763 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 2, 2023; 144 on October 2, 2023; 578 on May 31, 2024; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025; 578 on June 1, 2026 and 352 on June 2, 2026. |